Search

Author/Creator Stevens, D.

11. EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL. (12th June 2019)

Authors:
Morschhauser, F.; Ghosh, N.; Lossos, I.; Palomba, M.L.; Mehta, A.; Casasnovas, O.; Stevens, D.; Chitra, S.; Knapp, A.; Nielsen, T.; Oestergaard, M.; Wenger, M.; Salles, G.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. OP0018 A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL. (2nd June 2020)

Authors:
Hetland, M. L.; Haavardsholm, E. A.; Rudin, A.; Nordström, D.; Nurmohamed, M.; Gudbjornsson, B.; Lampa, J.; Hørslev-Petersen, K.; Uhlig, T.; Gröndal, G.; Ǿstergaard, M.; Heiberg, M.; Twisk, J.; Krabbe, S.; Lend, K.; Olsen, I.; Lindqvist, J.; Ekwall, A. K. H.; Grøn, K. L.; Kapetanovic, M. C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL. (23rd June 2022)

Authors:
Strati, P.; Coleman, M.; Stevens, D.; Ma, S.; Patti, C.; Levy, M.; Lossos, I. S.; Ramakrishnan Geethakumari, P.; Lam, S.; Calvo, R.; Higgins, K.; Budde, L.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1019
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML. (23rd June 2022)

Authors:
Daver, N.; Maris, M.; Ramchandren, R.; Bixby, D.; Doucette, K.; Mawad, R.; Egan, D.; Stevens, D.; Zonder, J.; Molloy, N.; Scheuber, A.; Bruns, I.; Mantzaris, I.; Konopleva, M.; Goldberg, A. D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1700
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA. (23rd June 2022)

Authors:
Belada, D.; Kopeckova, K.; Bergua Burgues, J. M.; Stevens, D.; Nowakowski, G. S.; Waldron-Lynch, M.; Hadar, N.; Weirather, J.; Lässig, C.; Blair, D.; Dreyling, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study. (15th December 2017)

Authors:
Zachariah, D.; Stevens, D.; Sidorowicz, G.; Spooner, C.; Rowell, N.; Taylor, J.; Kay, R.; Salek, M.S.; Kalra, P.R.
Journal:
International journal of cardiology
Issue:
Volume 249(2017)
Page Start:
313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗